Patents by Inventor Shanshan Song

Shanshan Song has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11955635
    Abstract: A single crystal multi-element positive electrode material and a preparation method therefor, and a lithium ion battery. The ratio of the length of the longest diagonal line to the length of the shortest diagonal line of the single crystal particles of the single crystal multi-element positive electrode material measured by an SEM is roundness R, and R?1; and D10, D50 and D90 of the single crystal particles of the single crystal multi-element positive electrode material satisfy: K90=(D90?D10)/D50, and the product of K90 and R is 1.20-1.40. The single crystal multi-element positive electrode material is more round and regular in morphology, the single crystal particles have uniform size, less agglomeration and less adhesion. The material has the characteristics of high compaction density, good rate capability and excellent cycle performance.
    Type: Grant
    Filed: October 30, 2023
    Date of Patent: April 9, 2024
    Assignee: Beijing Easpring Material Technology Co., Ltd.
    Inventors: Yiseng Hu, Shanshan Li, Shunlin Song, Yafei Liu, Yanbin Chen
  • Publication number: 20230167196
    Abstract: The invention discloses an anti-phenacetin monoclonal antibody hybridoma cell strain AD, a preparation method and application thereof, and relates to the technical field of food safety immunodetection. The monoclonal antibody hybridoma cell strain is named monoclonal cell strain AD and the number CGMCC19681. The Phe-BA obtained by the hydrolysis of the reaction product of the phenacetin metabolite acetaminophen and ethyl 4-bromobutyrate is used as the hapten, and the hapten is coupled with the carrier protein to prepare the immunogen Phe-BA-BSA. After the mice were immunized with the immunogen Phe-BA-BSA, they were fused with myeloma cells by PEG method, screened by indirect competitive enzyme-linked immunosorbent assay and subcloned five times to obtain hybridoma cell lines. The monoclonal antibody secreted by the cell line can be made into a phenacetin detection kit, which has good affinity and detection sensitivity for phenacetin, and can be used for immunodetection of phenacetin residues in food.
    Type: Application
    Filed: November 9, 2021
    Publication date: June 1, 2023
    Inventors: Chuanlai XU, Jingjing YAO, Hua KUANG, Liguang XU, Maozhong SUN, Xiaoling WU, Liqiang LIU, Wei MA, Jianping ZHU, Changlong HAO, Shanshan SONG, Yongming HU, Aihong WU, Lingling GUO, Xinxin XU
  • Publication number: 20230133974
    Abstract: A hybridoma cell line of secreting cyproheptadine monoclonal antibodies with a preservation number of CGMCC No. 14699 belongs to the field of food safety immunological detection. BALB/c mice are immunized through one time immunization with complete freund's adjuvant, three times of booster immunization with incomplete freund's adjuvant and one time of rush immunization with cyproheptadine complete antigen without adjuvant; the spleen cells from BALB/C mice immunized with high potency and low value of IC50 are fused with murine myeloma cells; and then the hybridoma cell line is obtained through indirect competitive ELISA screening and three sub-clones. The monoclonal antibody secreted by this cell line has good specificity and detection sensitivity to cyproheptadine (value of IC50 is 0.37 ng/ml), being suitable for detection of cyproheptadine in food.
    Type: Application
    Filed: December 27, 2022
    Publication date: May 4, 2023
    Inventors: Chuanlai XU, Hua KUANG, Wei JIANG, Liguang XU, Wei MA, Liqiang LIU, Xiaoling WU, Shanshan SONG, Yongming HU
  • Patent number: 11603414
    Abstract: A hybridoma cell line of secreting cyproheptadine monoclonal antibodies with a preservation number of CGMCC No. 14699 belongs to the field of food safety immunological detection. BALB/c mice are immunized through one time immunization with complete freund's adjuvant, three times of booster immunization with incomplete freund's adjuvant and one time of rush immunization with cyproheptadine complete antigen without adjuvant; the spleen cells from BALB/C mice immunized with high potency and low value of IC50 are fused with murine myeloma cells; and then the hybridoma cell line is obtained through indirect competitive ELISA screening and three sub-clones. The monoclonal antibody secreted by this cell line has good specificity and detection sensitivity to cyproheptadine (value of IC50 is 0.37 ng/ml), being suitable for detection of cyproheptadine in food.
    Type: Grant
    Filed: December 17, 2018
    Date of Patent: March 14, 2023
    Assignee: JIANGNAN UNIVERSITY
    Inventors: Chuanlai Xu, Hua Kuang, Wei Jiang, Liguang Xu, Wei Ma, Liqiang Liu, Xiaoling Wu, Shanshan Song, Yongming Hu
  • Publication number: 20220235061
    Abstract: The present disclosure relates to triazolopyrimidine compounds and salts, compositions and uses thereof, and the triazolopyrimidine compounds have the structures represented by the formula (I): the above-mentioned triazolopyrimidine compounds have good activity and high selectivity for NAE.
    Type: Application
    Filed: June 12, 2020
    Publication date: July 28, 2022
    Inventors: Ao ZHANG, Zehong MIAO, Chaodong XIONG, Shanshan SONG, Jinxue HE
  • Publication number: 20220010029
    Abstract: A hybridoma cell strain secreting anti-dinitolmide monoclonal antibodies deposited at China General Microbiological Culture Collection Center (CGMCC) at No. 1 West Beichen Road, Chaoyang District, Beijing 100101, China on Nov. 28, 2019, with deposit number of CGMCC No. 19165. It is classified as a monoclonal cell strain. The monoclonal antibody secreted by the hybridoma cell strain DAS3H10 has a good affinity and high sensitivity to dinitolmide. Because of IC50 to dinitolmide up to 9.01 ng/mL, the monoclonal antibody could be used to prepare dinitolmide immunoassay kit and colloidal gold test strip and provides a powerful detection method and means for the detection of dinitolmide in animal-derived foods.
    Type: Application
    Filed: July 6, 2021
    Publication date: January 13, 2022
    Inventors: Chuanlai XU, JIE LIU, HUA KUANG, Liguang XU, Maozhong SUN, Liqiang LIU, Xiaoling WU, Changlong HAO, Shanshan SONG, Yongming HU, Qiankun ZHENG
  • Patent number: 11078188
    Abstract: The present invention relates to dihydroquinoxaline bromodomain recognition protein inhibitor, preparation method and use thereof. The inhibitor of the present invention is compound represented by general formula (I), or stereoisomer, pharmaceutically acceptable salt, prodrug, solvate, hydrate and crystal form thereof. The definition of each substituent is as described in the description and claims. The compound represented by general formula (I) of the present invention may inhibit bromodomain recognition protein and may be used for preparing medicament which regulates the apparent state of cells and treats series of diseases and symptoms which are mediated by the bromodomain recognition protein.
    Type: Grant
    Filed: March 5, 2018
    Date of Patent: August 3, 2021
    Assignee: SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES
    Inventors: Bing Xiong, Jingkang Shen, Zehong Miao, Jianping Hu, Yingqing Wang, Shanshan Song, Tao Meng
  • Patent number: 11010267
    Abstract: A computer program product, system, and computer implemented method for automatic maintenance of standby databases for non-logged workloads, the process comprising: maintaining a redo stream of redo records sent from a primary database to a standby database, identifying a change made at the primary database for which a redo record was not created, inserting a placeholder redo record into the redo stream corresponding to the change identified at the primary database for which the redo record was not created, sending, to the standby database, a copy of one or more data blocks corresponding to the change that is associated with the placeholder redo record, receiving the placeholder redo record from the redo stream, identifying the copy of the one or more data blocks sent from the primary database corresponding to the placeholder redo record, and applying the copy of one or more data blocks to update the standby database.
    Type: Grant
    Filed: November 30, 2017
    Date of Patent: May 18, 2021
    Assignee: Oracle International Corporation
    Inventors: Ian Stuart Neall, Yunrui Li, Steven J. Mcgee, Yi Ding, German Shegalov, Shanshan Song
  • Patent number: 10882896
    Abstract: A hybridoma cell strain secreting a nifursol residue marker monoclonal antibody prepared in the following way: BALB/c mice are subjected to the first immunization with a complete Freund's adjuvant, subjected to booster immunization with an incomplete Freund's adjuvant for four times, and subjected to rush immunization once with nifursol residue marker complete antigen without a Freund's adjuvant so that the BALB/c mice are immunized; the spleen cells of the immunized mice with high titer and low IC50 were fused with mouse myeloma cells by a PEG method, and the fused cells are screened through indirect competitive ELISA and subcloned three times. The monoclonal antibody secreted by this cell strain has good specificity and detection sensitivity (IC50 value of 2 ?g/L) to the nifursol residue marker and can be used for residue detection of the nifursol residual marker in food.
    Type: Grant
    Filed: July 21, 2020
    Date of Patent: January 5, 2021
    Assignee: JIANGNAN UNIVERSITY
    Inventors: Hua Kuang, Chuanlai Xu, Aihong Wu, Liguang Xu, Wei Ma, Liqiang Liu, Xiaoling Wu, Shanshan Song, Yongming Hu
  • Publication number: 20200347119
    Abstract: A hybridoma cell strain secreting a nifursol residue marker monoclonal antibody prepared in the following way: BALB/c mice are subjected to the first immunization with a complete Freund's adjuvant, subjected to booster immunization with an incomplete Freund's adjuvant for four times, and subjected to rush immunization once with nifursol residue marker complete antigen without a Freund's adjuvant so that the BALB/c mice are immunized; the spleen cells of the immunized mice with high titer and low IC50 were fused with mouse myeloma cells by a PEG method, and the fused cells are screened through indirect competitive ELISA and subcloned three times. The monoclonal antibody secreted by this cell strain has good specificity and detection sensitivity (IC50 value of 2 ?g/L) to the nifursol residue marker and can be used for residue detection of the nifursol residual marker in food.
    Type: Application
    Filed: July 21, 2020
    Publication date: November 5, 2020
    Inventors: Hua KUANG, Chuanlai XU, Aihong WU, Liguang XU, Wei MA, Liqiang LIU, Xiaoling WU, Shanshan SONG, Yongming HU
  • Patent number: 10808041
    Abstract: The present disclosure discloses a lincosamides universal monoclonal antibody hybridoma cell strain and application thereof, and belongs to the technical field of food safety immunological detection. According to the present disclosure, a clindamycin chlorine-substituted derivative is used as a hapten, the hapten is coupled with bovine serum albumin (BSA) by an activated ester method to obtain an immunizing antigen, and after being uniformly mixed with a Freund's adjuvant, the immunizing antigen is subcutaneously injected to immunize BALB/c mice; clindamycin is coupled with ovalbumin (OVA) by a carbonyl diimidazole (CDI) method to be used as a coating antigen used for detecting mouse serums and a cell supernatant. The spleen cells of the immunized mice are fused with mouse myeloma cells by a PEG method, and screened by indirect ELISA and indirect competitive ELISA and subcloned three times to obtain a population-selective hybridoma cell strain.
    Type: Grant
    Filed: November 28, 2019
    Date of Patent: October 20, 2020
    Assignee: Jiangnan University
    Inventors: Hua Kuang, Lingling Guo, Chuanlai Xu, Liguang Xu, Wei Ma, Liqiang Liu, Shanshan Song, Xiaoling Wu
  • Patent number: 10759845
    Abstract: A hybridoma cell strain secreting a nifursol residue marker monoclonal antibody with CGMCC No. 18525 is prepared in the following way: BALB/c mice are subjected to the first immunization with a complete Freund's adjuvant, subjected to booster immunization with an incomplete Freund's adjuvant for four times, and subjected to rush immunization once with nifursol residue marker complete antigen without a Freund's adjuvant so that the BALB/c mice are immunized; the spleen cells of the immunized mice with high titer and low IC50 were fused with mouse myeloma cells by a PEG method, and the fused cells are screened through indirect competitive ELISA and subcloned three times. The monoclonal antibody secreted by this cell strain has good specificity and detection sensitivity (IC50 value of 2 ?g/L) to the nifursol residue marker and can be used for residue detection of the nifursol residual marker in food.
    Type: Grant
    Filed: December 17, 2018
    Date of Patent: September 1, 2020
    Inventors: Hua Kuang, Chuanlai Xu, Aihong Wu, Liguang Xu, Wei Ma, Liqiang Liu, Xiaoling Wu, Shanshan Song, Yongming Hu
  • Patent number: 10696748
    Abstract: A hybridoma cell line of secreting clarithromycin monoclonal antibodies with a preservation number of hybridoma cell line of CGMCC No. 14696 belongs to the field of food safety immunological detection. BALB/c mice are immunized through one time immunization with complete freund's adjuvant, three times of booster immunization with incomplete freund's adjuvant and one time of rush immunization with clarithromycin complete antigen without adjuvant; the spleen cells from BALB/C mice immunized with high potency and low value of IC50 are fused with murine myeloma cells; and then the hybridoma cell line is obtained through indirect competitive ELISA screening and three subclones. The monoclonal antibody secreted by this cell line has good specificity and detection sensitivity to clarithromycin (value of IC50 is 0.3 ng/ml), being suitable for detection of clarithromycin in food.
    Type: Grant
    Filed: April 25, 2019
    Date of Patent: June 30, 2020
    Assignee: JIANGNAN UNIVERSITY
    Inventors: Chuanlai Xu, Hua Kuang, Lu Zeng, Liguang Xu, Liqiang Liu, Shanshan Song, Xiaoling Wu, Yongming Hu
  • Publication number: 20200095337
    Abstract: The present disclosure discloses a lincosamides universal monoclonal antibody hybridoma cell strain and application thereof, and belongs to the technical field of food safety immunological detection. According to the present disclosure, a clindamycin chlorine-substituted derivative is used as a hapten, the hapten is coupled with bovine serum albumin (BSA) by an activated ester method to obtain an immunizing antigen, and after being uniformly mixed with a Freund's adjuvant, the immunizing antigen is subcutaneously injected to immunize BALB/c mice; clindamycin is coupled with ovalbumin (OVA) by a carbonyl diimidazole (CDI) method to be used as a coating antigen used for detecting mouse serums and a cell supernatant. The spleen cells of the immunized mice are fused with mouse myeloma cells by a PEG method, and screened by indirect ELISA and indirect competitive ELISA and subcloned three times to obtain a population-selective hybridoma cell strain.
    Type: Application
    Filed: November 28, 2019
    Publication date: March 26, 2020
    Inventors: Hua KUANG, Lingling GUO, Chuanlai XU, Liguang XU, Wei MA, Liqiang LIU, Shanshan SONG, Xiaoling WU
  • Patent number: 10597399
    Abstract: A class of substituted triazolopiperazine compounds represented by formula (I), tautomers, enantiomers, diastereomers, racemates, metabolites, metabolic precursors, and pharmaceutically acceptable salts, esters, prodrugs or hydrate thereof, a preparation methods therefor, intermediates and a use thereof in the preparation of drugs for prevention and treatment of diseases associated with PARP including various ischemic diseases, neurodegenerative diseases and cancers.
    Type: Grant
    Filed: May 23, 2018
    Date of Patent: March 24, 2020
    Assignee: Shanghai Institute of Materia Medica, Chinese Academy of Sciences
    Inventors: Ao Zhang, Zehong Miao, Pingyuan Wang, Shanshan Song, Zilan Song, Xiajuan Huan, Zhoulong Fan, Jian Ding
  • Patent number: 10562979
    Abstract: A hybridoma cell line of secreting meloxicam monoclonal antibodies with a preservation number of hybridoma cell line of CGMCC No. 14700 belongs to the field of food safety immunological detection. The. BALB/c mice are immunized through one time immunization with complete freund's adjuvant, three times of booster immunization with incomplete freund's adjuvant and one time of rush immunization with meroxicam complete antigen without adjuvant; the spleen cells from BALB/C mice immunized with high potency and low value of IC50 are fused with murine myeloma cells; and then the hybridoma cell line is obtained through indirect competitive ELISA screening and three sub-clones. The monoclonal antibody secreted by this cell line has good specificity and detection sensitivity to meloxicam (value of IC50 is 0.1 ng/ml), being suitable for detection of meroxicam in food.
    Type: Grant
    Filed: December 17, 2018
    Date of Patent: February 18, 2020
    Assignee: JIANGNAN UNIVERSITY
    Inventors: Hua Kuang, Chuanlai Xu, Lu Lin, Liguang Xu, Wei Ma, Liqiang Liu, Xiaoling Wu, Shanshan Song, Yongming Hu
  • Publication number: 20200048329
    Abstract: A hybridoma cell strain secreting a nifursolol residue marker monoclonal antibody with CGMCC No. 14698 is prepared in the following way: BALB/c mice are subjected to the first immunization with a complete Freund's adjuvant, subjected to booster immunization with an incomplete Freund's adjuvant for four times, and subjected to rush immunization once with nifursolol residue marker complete antigen without a Freund's adjuvant so that the BALB/c mice are immunized; the spleen cells of the immunized mice with high titer and low IC50 were fused with mouse myeloma cells by a PEG method, and the fused cells are screened through indirect competitive ELISA and subcloned three times. The monoclonal antibody secreted by this cell strain has good specificity and detection sensitivity (IC50 value of 2 ?g/L) to the nifursolol residue marker and can be used for residue detection of the nifursolol residual marker in food.
    Type: Application
    Filed: December 17, 2018
    Publication date: February 13, 2020
    Inventors: Hua KUANG, Chuanlai XU, Aihong WU, Liguang XU, Wei MA, Liqiang LIU, Xiaoling WU, Shanshan SONG, Yongming HU
  • Publication number: 20200040106
    Abstract: A hybridoma cell line of secreting meloxicam monoclonal antibodies with a preservation number of hybridoma cell line of CGMCC No. 14700 belongs to the field of food safety immunological detection. The. BALB/c mice are immunized through one time immunization with complete freund's adjuvant, three times of booster immunization with incomplete freund's adjuvant and one time of rush immunization with meroxicam complete antigen without adjuvant; the spleen cells from BALB/C mice immunized with high potency and low value of IC50 are fused with murine myeloma cells; and then the hybridoma cell line is obtained through indirect competitive ELISA screening and three sub-clones. The monoclonal antibody secreted by this cell line has good specificity and detection sensitivity to meloxicam (value of IC50 is 0.1 ng/ml), being suitable for detection of meroxicam in food.
    Type: Application
    Filed: December 17, 2018
    Publication date: February 6, 2020
    Inventors: Hua KUANG, Chuanlai XU, Lu LIN, Liguang XU, Wei MA, Liqiang LIU, Xiaoling WU, Shanshan SONG, Yongming HU
  • Publication number: 20200031802
    Abstract: The present invention relates to dihydroquinoxaline bromodomain recognition protein inhibitor, preparation method and use thereof. The inhibitor of the present invention is compound represented by general formula (I), or stereoisomer, pharmaceutically acceptable salt, prodrug, solvate, hydrate and crystal form thereof. The definition of each substituent is as described in the description and claims. The compound represented by general formula (I) of the present invention may inhibit bromodomain recognition protein and may be used for preparing medicament which regulates the apparent state of cells and treats series of diseases and symptoms which are mediated by the bromodomain recognition protein.
    Type: Application
    Filed: March 5, 2018
    Publication date: January 30, 2020
    Inventors: Bing XIONG, Jingkang SHEN, Zehong MIAO, Jianping HU, Yingqing WANG, Shanshan SONG, Tao MENG
  • Publication number: 20190284304
    Abstract: A hybridoma cell line of secreting clarithromycin monoclonal antibodies with a preservation number of hybridoma cell line of CGMCC No. 14696 belongs to the field of food safety immunological detection. BALB/c mice are immunized through one time immunization with complete freund's adjuvant, three times of booster immunization with incomplete freund's adjuvant and one time of rush immunization with clarithromycin complete antigen without adjuvant; the spleen cells from BALB/C mice immunized with high potency and low value of IC50 are fused with murine myeloma cells; and then the hybridoma cell line is obtained through indirect competitive ELISA screening and three subclones. The monoclonal antibody secreted by this cell line has good specificity and detection sensitivity to clarithromycin (value of IC50 is 0.3 ng/ml), being suitable for detection of clarithromycin in food.
    Type: Application
    Filed: April 25, 2019
    Publication date: September 19, 2019
    Inventors: Chuanlai XU, Hua KUANG, Lu ZENG, Liguang XU, Liqiang LIU, Shanshan SONG, Xiaoling WU, Yongming HU